Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial
AbstractObjectives1. To compare the safety and efficacy of Hydroxychloroquine with Ribavirin and standard treatment in patients with non-severe COVID-19 infection2. To compare the safety and efficacy of standard treatment, Lopinavir-ritonavir with Ribavarin, and Hydroxychloroquine with Ribavirin in patients with severe COVID-19 infectionTrial designThe study is an Open label, Parallel arm design, stratified randomised controlled trial. Patients will be categorised as non-severe or severe based on predefined criteria. Those who satisfy all inclusion criteria and no exclusion criteria in the respective categories, will be ra...
Source: Trials - October 20, 2020 Category: Research Source Type: clinical trials
The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19
Condition: Covid19 Interventions: Drug: Favipiravir; Drug: Oseltamivir 75mg Sponsor: Indonesia University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2020 Category: Research Source Type: clinical trials
